Information  X 
Enter a valid email address

Vindon HealthcarePlc (VDN)

  Print      Mail a friend       Annual reports

Wednesday 18 September, 2013

Vindon HealthcarePlc

Cancellation of Admission to Trading on AIM

RNS Number : 2441O
Vindon Healthcare Plc
18 September 2013

18 September 2013


Vindon Healthcare plc

("Vindon" or the "Company")



Cancellation of Admission to Trading on AIM


The Company announces that it has applied to the London Stock Exchange for the cancellation of trading of Vindon's shares on AIM. In accordance with AIM Rule 41, cancellation will take place no earlier than 20 business days from today's date and it is currently anticipated that cancellation will take effect from 7.00 a.m. on 16 October 2013.


This follows the announcement earlier today by Source BioScience plc ("Source BioScience") that its recommended cash offer ("Offer") to acquire the whole of the issued and to be issued share capital of Vindon had been declared wholly unconditional and that it intended to procure that Vindon applied for the cancellation of trading of the Company's shares on AIM. In the same announcement, Source BioScience stated that it intended, pursuant to its rights under sections 974 to 991 (inclusive) of the Companies Act 2006, to acquire compulsorily all of the Vindon shares in respect of which valid acceptances of the Offer had not been received.


Vindon shareholders should note that cancellation is likely to reduce significantly the liquidity and marketability of Vindon shares. Once cancellation has taken effect, Vindon shareholders will no longer be able to effect transactions in Vindon shares on market at the market price. Following cancellation, therefore, Vindon shareholders will have to effect any further transactions in Vindon shares off market at a price to be agreed between the relevant parties. Shareholders are still able to buy and sell Vindon shares prior to the cancellation.



Vindon Healthcare plc

Liam Ferguson, Chairman

Tel: +44 (0) 1706 716710

Email: [email protected]


For investor and media enquiries:


WH Ireland Limited

Dan Bate (Nominated Adviser)

Jessica Metcalf (Corporate Broking)

Tel: +44(0)161 832 2174


Zeus Capital Limited (Financial Advisor)

Andrew Jones / Nick Cowles

Tel: +44 (0)161 831 1512


The Communications Portfolio

Ariane Comstive

Tel: +44 (0) 20 7536 2028/29

This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t